Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 551-555

  Lavrenčič, Aleša ^a,b   Salobir, Barbara Gužič ^a   Keber, Irena ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Research and Development   (Slovenia)

Author keywords

Conduit arteries; Flow mediated dilation; Physical training; Polymetabolic syndrome; Ultrasonography

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIG ENDOTHELIN 1; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; HEART RATE; HUMAN; HYPEREMIA; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TRAINING; VASODILATATION;

EID: 0343920844     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.551     Document Type: Article

References (36)

1. Kannel WB, Wilson P, Blair AN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J. 1985;109:876-885.
2. Hakim AA, Petrovitch H, Burchfiel CM, Ross GW, Rodriguez BL, White LR, Yano K, Curb D, Abbott RD. Effects of walking on mortality among nonsmoking retired men. N Engl J Med. 1998;338:94-99.
3. Bijnen FCH, Caspersen CJ, Feskens EJM, Saris WHM, Mosterd WL, Kromhout D. Physical activity and 10-year mortality from cardiovascular diseases and all causes. Arch Intern Med. 1998;158:1499-1505.
4. Stray-Gundersen J, Denke MA, Grundy SM. Influence of life-time cross-country skiing on plasma lipids and lipoproteins. Med Sci Sports Exerc. 1991;23:695-702.
5. Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Hwang LJ, Marcus EB, Yano K. Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol. 1995;141:360-368.
6. Fagard RH. Prescription and results of physical activity. J Cardiovasc Pharmacol. 1995;25(suppl 1):20-27.
7. Schuit AJ, Schouten EG. Kluft C, De Maat M, Menheere PPCA, Kok FJ. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost. 1997;78:845-851.
8. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
10. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:50-55.
11. Celermajer DS. Endothelial dysfunction: does it matter? is it reversible? J Am Coll Cardiol 1997;30:325-333.
12. Wieczorek KM, Brewer AS, Myatt L. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol. 1995;173:708-713.
13. Hutcheson IR, Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol. 1991;261:H257-H262.
14. Miller VM, Aarhus LL, Vanhoutte PM. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol. 1986;251:H520-H527.
15. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 1993;73:829-838.
16. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74: 349-353.
17. Kingwell BA, Sherrard B, Jennings GL, Dart AM. Four weeks of cycle training increases basal production of nitric oxide from the forearm. Am J Physiol. 1997;272:H1070-H1077.
18. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93: 210-214.
19. Katz SD, Yuen J, Bijou R, LeJemtel TH. Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure. J Appl Physiol. 1997;82:1488-1492.
20. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu J, Adams V, Niebauer J, Schuler G. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation. 1998;98:2709-2715.
21. Arnesen H. Introduction: the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8):S1-S4.
22. Davidson MB. Clinical implications of insulin resistance syndromes. Am J Med. 1995;99:420-426.
23. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998;81:18B-25B.
24. Chaitman B. Exercise stress testing. In: Braunwald E, ed. Heart Disease, a Textbook of Cardiovascular Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 1992:161-179.
25. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
26. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International federation of clinical chemistry standardization project for measurements of apolipoproteins A1 and B. Clin Chem. 1994;40: 586-592.
27. Brandsom A, Johnson O. Dahlén GH, Rånby M. Lp(a) levels in healthy population measured by a new enzyme linked immunosorbent assay. Thromb Haemost. 1989;62:573.
28. Müllner S, Neubauer H, König W. A radioimmunoassay for the determination of insulins from several animal species, insulin derivatives and insulin precursors in both their native and denatured state. J Immunol Methods. 1991;140:211-218.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
30. D'Orleans JP, Lidbury PS, Warner TD, Vane JR. Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit. Biochem Pharmacol. 1990;39:R21-R22.
31. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3-17.
32. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:2092-2096.
33. Huonker M, Halle M, Keul J. Structural and functional adaptations of the cardiovascular system by training. Int J Sports Med. 1996:17(suppl 3):S164-S172.
34. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol. 1990;16:357-358.
35. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988;94:1020-1022.
36. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.